BioMarin Pharmaceutical Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
Top Picks For 2023: Catalyst Pharmaceuticals
Article By: MoneyShow.com
Monday, January 2, 2023 12:30 PM EDT
Catalyst Pharmaceuticals is a small-cap biopharma company focused on in-licensing, developing, and commercializing novel medicines to treat rare diseases. Let's take a closer look to see why it's a top pick for 2023.
In this article: CPRX Also: ESALY, BMRN
Read
Bear Market Bets In Biotech
Article By: MoneyShow.com
Monday, February 7, 2022 9:44 AM EDT
Taken together, the SPDR S&P Biotech ETF easily broke below the long-term 200-week support for the first time since the pandemic originally hit the markets in March of 2020.
In this article: ACAD, BMRN, CLDX, INCY, PCRX, IONS, MDGL, MYOV
Read
Futures Resume Tumbling After Yields Spike To New 2 Year High
Article By: Tyler Durden
Monday, January 10, 2022 8:24 AM EDT
US index futures traded down to session lows as US traders sat at their desks after rising modestly earlier in the session, and were down 27 points or 0.6% at 730am.
In this article: EDU, TAL, ADDYY, BMRN, ZS
Read
4 Biotechs That Could Be Potential Acquisition Targets In 2021
Article By: Zacks Investment Research
Thursday, December 17, 2020 10:24 PM EDT
Stocks of these companies have not fully recovered from the stock-market crash in March 2020, suggesting attractive valuations.
In this article: BMRN, QURE, RGNX, DCPH
Read
Top Six Long-Term Earnings Growth Stocks
Article By: Fred Fuld III
Thursday, December 17, 2020 8:44 AM EDT
It seems that some stocks, especially IPOs and former SPACs, have been trading at nosebleed levels with no earnings whatsoever. At some point, investors will start to concentrate on the fundamentals.
In this article: MTOR, USM, TROX, BMRN, PKBK, SUPN
Read
All Posts

Latest Tweets for $BMRN

No tweets yet!

PARTNER HEADLINES